Evidence map›Paper›PMID 42210644›Full record

ArticleClinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery2026

Prognostic Analysis of Patients With N1 Nasopharyngeal Carcinoma With Different Lymph Node Characteristics.

Jie Yang, Ying Lu, Hui Yang, Zhuo-Hua Xu, Zhou Jiang, Xi-Yan Tan, Xi-Shan Chen

Abstract read
In one paragraph

Article in Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jie YangDepartment of Oncology, Liuzhou Worker's Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China.
Ying LuDepartment of Oncology, Liuzhou Worker's Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China.
Hui YangDepartment of Oncology, Liuzhou Worker's Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China.
Zhuo-Hua XuDepartment of Oncology, Liuzhou Worker's Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China.
Zhou JiangDepartment of Oncology, Liuzhou Worker's Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China.
Xi-Yan TanDepartment of Oncology, Liuzhou Worker's Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China.
Xi-Shan ChenDepartment of Oncology, Liuzhou Worker's Hospital, Liuzhou, Guangxi Zhuang Autonomous Region, China.ORCID https://orcid.org/0000-0002-9716-2908

Funding

Guangxi Natural Science Foundation Project 2024GXNSFAA010116Science and Technology Program of Liuzhou City 2022CAC0111Scientific Research Project of Guangxi Zhuang Autonomous Region Administration of Traditional Chinese Medicine GXZYB20240612Youth Science Foundation of Guangxi Medical University GXMUYSF 202229
6 · The paper itself

Abstract

backgroundPrognosis in patients with N1 nasopharyngeal carcinoma (NPC) remains heterogeneous, partly due to variations in lymph node involvement. This study evaluated the prognostic significance of different lymph node characteristics in N1 NPC.

methodsWe retrospectively analysed 160 newly diagnosed non-metastatic N1 NPC patients treated at Liuzhou Worker's Hospital from January 2017 to May 2023. Kaplan-Meier curves were used to estimate survival outcomes, and Cox regression analysis was performed to identify independent prognostic factors.

resultsAmong the 160 patients, 57 had retropharyngeal lymph nodes (RLNs) only, 24 had cervical lymph nodes (CLNs) only, and 79 had concurrent CLNs and RLNs involvement. The 5-year overall survival (OS), progression-free survival (PFS), locoregional relapse-free survival (LRRFS), and distant metastasis-free survival (DMFS) rates were 94.7%, 80.1%, 89.6%, and 88.8%, respectively. Patients with concurrent CLNs and RLNs involvement had worse OS than those with single-region involvement (5-year OS: 90.2% vs. 98.4%, p = 0.0238). Subgroup analysis showed that in T1-2 patients, combined nodal involvement was associated with inferior OS, PFS, and LRRFS, whereas no significant survival differences were observed in T3-4 patients. Multivariate analysis identified lymph node necrosis (LNN) as an independent adverse prognostic factor for LRRFS (HR = 4.056; 95% CI: 1.262-13.035; p = 0.019).

conclusionLymph node characteristics further refine prognostic stratification in N1 NPC. Concurrent CLNs and RLNs involvement was associated with poorer survival, particularly in early T-stage disease, while LNN was associated with an increased risk of locoregional recurrence.

Indexed as

Lymph NodesNasopharyngeal CarcinomaNasopharyngeal NeoplasmsAdultAgedFemaleHumansLymphatic MetastasisMaleMiddle AgedNeoplasm StagingPrognosisRetrospective StudiesSurvival Ratecervical lymph nodeslymph nodenasopharyngeal carcinomaretropharyngeal lymph node

Identifiers

PMID42210644
PMCPMC13432558

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.